Updated Mar 16, 2021 | 09:52 IST
Of the total Rs 800 crore funds of Rs 500 crore will flow to the company and will be utilized towards capacity expansion in SI business and towards expansion in the fluorospeciality chemicals. Representational Image 
Laxmi Organics IPO issue opens today (March 15, 2021) and closes on March 17, 2021. The price band of Rs 129 to Rs 130 per share.
Laxmi Organic Industries (“Laxmi Organic”) was incorporated on May 15, 1989. The company is a leading manufacturer of Acetyl Intermediates (AI) and Specialty Intermediates (SI) with almost 3 decades of experience in the large scale manufacturing of chemicals.
Laxmi Organic is currently among the largest manufacturers of ethyl acetate in India with a market share of approximately 30% of the Indian ethyl acetate market. In 2010, Laxmi Organic commenced manufacturing the Specialty Intermediates by acquiring Clariant’s diketene business. The company is the only manufacture
Laxmi Organic Industries IPO subscribed 2 28 times
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.
Laxmi Organic Industries initial public offer (IPO) To Open On March 15
ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.
Laxmi Organic Industries IPO: 10 key things to know before subscribing the issue © Sunil Matkar Laxmi Organic Industries IPO: 10 key things to know before subscribing the issue
Laxmi Organic Industries, a specialty chemicals manufacturer, will open its initial public offering for subscription in the coming week, which will be busy with five IPOs lined up for launch.
Laxmi Organics shares are going to be listed on the BSE as well as National Stock Exchange. Axis Capital and DAM Capital Advisors (formerly IDFC Securities) are the lead managers to the offer.
Here are 10 things to know before investing in the public issue: